Opportunistic Infections Citation List: January 30 - February 12, 2015

ANTIFUNGAL COMPOUNDS (includes Cryptococcus, Aspergillus, Candida, & Histoplasma)

1. Antimicrobial and Cytotoxic Activity of Ferula gummosa Plant Essential Oil Compared to NaOCl and CHX: A Preliminary in Vitro Study. Abbaszadegan, A., A. Gholami, H. Mirhadi, M. Saliminasab, A. Kazemi, and M.R. Moein. Restorative Dentistry & Endodontics, 2015. 40(1): p. 50-57. PMID[25671213].

[PubMed]. OI_0130-021215.

2. Mohangamides A and B, New Dilactone-tethered Pseudo-dimeric Peptides Inhibiting Candida albicans Isocitrate Lyase. Bae, M., H. Kim, K. Moon, S.J. Nam, J. Shin, K.B. Oh, and D.C. Oh. Organic Letters, 2015. 17(3): p. 712-715. PMID[25622093].

[PubMed]. OI_0130-021215.

3. Antibacterial Compounds from Salvia adenophora Fernald (Lamiaceae). Bisio, A., A.M. Schito, S.N. Ebrahimi, M. Hamburger, G. Mele, G. Piatti, G. Romussi, F. Dal Piaz, and N. De Tommasi. Phytochemistry, 2015. 110: p. 120-132. PMID[25435172].

[PubMed]. OI_0130-021215.

4. In Vitro Activity of 23 Tea Extractions and Epigallocatechin gallate against Candida Species. Chen, M., L. Zhai, and M.C. Arendrup. Medical Mycology, 2015. 53(2): p. 194-198. PMID[25605775].

[PubMed]. OI_0130-021215.

5. Novel Triazole Alcohol Antifungals Derived from Fluconazole: Design, Synthesis, and Biological Activity. Hashemi, S.M., H. Badali, M.A. Faramarzi, N. Samadi, M.H. Afsarian, H. Irannejad, and S. Emami. Molecular Diversity, 2015. 19(1): p. 15-27. PMID[25182365].

[PubMed]. OI_0130-021215.

6. In Vitro Interactions between Farnesol and Fluconazole, Amphotericin B or Micafungin against Candida albicans Biofilms. Katragkou, A., M. McCarthy, E.L. Alexander, C. Antachopoulos, J. Meletiadis, M.A. Jabra-Rizk, V. Petraitis, E. Roilides, and T.J. Walsh. Journal of Antimicrobial Chemotherapy, 2015. 70(2): p. 470-478. PMID[25288679].

[PubMed]. OI_0130-021215.

7. Design, Synthesis, and Biological Evaluation of Aminothiazole Derivatives against the Fungal Pathogens Histoplasma capsulatum and Cryptococcus neoformans. Khalil, A., J.A. Edwards, C.A. Rappleye, and W. Tjarks. Bioorganic & Medicinal Chemistry, 2015. 23(3): p. 532-547. PMID[25543205].

[PubMed]. OI_0130-021215.

8. Synergistic Activity of Chloroquine with Fluconazole against Fluconazole-resistant Isolates of Candida Species. Li, Y., Z. Wan, W. Liu, and R. Li. Antimicrobial Agents and Chemotherapy, 2015. 59(2): p. 1365-1369. PMID[25512426].

[PubMed]. OI_0130-021215.

9. Antibiofilm Potential of Flavonoids Extracted from Moringa oleifera Seed Coat against Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans. Onsare, J.G. and D.S. Arora. Journal of Applied Microbiology, 2015. 118(2): p. 313-325. PMID[25410525].

[PubMed]. OI_0130-021215.

10. Susceptibility Characterisation of Candida Spp. to Four Essential Oils. Rath, C.C. and S. Mohapatra. Indian Journal of Medical Microbiology, 2015. 33 Suppl: p. S93-S96. PMID[25657164].

[PubMed]. OI_0130-021215.

11. Anti-tuberculous Activity of Treponemycin Produced by a Streptomyces Strain MS-6-6 Isolated from Saudi Arabia. Yassien, M.A., H.M. Abdallah, A.M. El-Halawany, and A.A. Jiman-Fatani. Molecules, 2015. 20(2): p. 2576-2590. PMID[25648598].

[PubMed]. OI_0130-021215.

12. Histone Deacetylase Inhibitors for Enhancing Activity of Antifungal Agent: A Patent Evaluation of WO2014041424(A1). Zhang, L. and W. Xu. Expert Opinion on Therapeutic Patents, 2015. 25(2): p. 237-240. PMID[25381141].

[PubMed]. OI_0130-021215.

ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)

13. Rapid Cytolysis of Mycobacterium tuberculosis by Faropenem, an Orally Bioavailable Beta-lactam Antibiotic. Dhar, N., V. Dubee, L. Ballell, G. Cuinet, J.E. Hugonnet, F. Signorino-Gelo, D. Barros, M. Arthur, and J.D. McKinney. Antimicrobial Agents and Chemotherapy, 2015. 59(2): p. 1308-1319. PMID[25421469].

[PubMed]. OI_0130-021215.

14. Enabling the (3 + 2) Cycloaddition Reaction in Assembling Newer Anti-tubercular Lead Acting through the Inhibition of the Gyrase ATPase Domain: Lead Optimization and Structure Activity Profiling. Jeankumar, V.U., R.S. Reshma, R. Janupally, S. Saxena, J.P. Sridevi, B. Medapi, P. Kulkarni, P. Yogeeswari, and D. Sriram. Organic & Biomolecular Chemistry, 2015. 13(8): p. 2423-2431. PMID[25569565].

[PubMed]. OI_0130-021215.

15. In Vitro Activities of Linezolid against Clinical Isolates of Mycobacterium tuberculosis from Shenyang, North of China. Liu, H., Y. Wang, N. Liu, and L. Zhao. Indian Journal of Medical Microbiology, 2015. 33 Suppl: p. S164-S165. PMID[25657144].

[PubMed]. OI_0130-021215.

16. Total Synthesis of the Protected Aglycon of Fidaxomicin (Tiacumicin B, Lipiarmycin A3). Miyatake-Ondozabal, H., E. Kaufmann, and K. Gademann. Angewandte Chemie, 2015. 54(6): p. 1933-1936. PMID[25431322].

[PubMed]. OI_0130-021215.

17.Pharmacophore Based Virtual Screening, Synthesis and SAR of Novel Inhibitors of Mycobacterium sulfotransferase. Saha, R., O. Tanwar, M.M. Alam, M.S. Zaman, S.A. Khan, and M. Akhter. Bioorganic & Medicinal Chemistry Letters, 2015. 25(3): p. 701-707. PMID[25541388].

[PubMed]. OI_0130-021215.

18. Delamanid (OPC-67683) for Treatment of Multi-drug-resistant Tuberculosis. Sotgiu, G., E. Pontali, R. Centis, L. D'Ambrosio, and G.B. Migliori. Expert Review of Anti-infective Therapy, 2015. 13(3): p. 305-315. PMID[25645397].

[PubMed]. OI_0130-021215.

19. Design and Synthesis of Novel Carbazole Tethered Pyrrole Derivatives as Potent Inhibitors of Mycobacterium tuberculosis. Surineni, G., P. Yogeeswari, D. Sriram, and S. Kantevari. Bioorganic & Medicinal Chemistry Letters, 2015. 25(3): p. 485-491. PMID[25559743].

[PubMed]. OI_0130-021215.

20. A Rho GDP Dissociation Inhibitor Produced by Apoptotic T-cells Inhibits Growth of Mycobacterium tuberculosis. Venkatasubramanian, S., R. Dhiman, P. Paidipally, S.S. Cheekatla, D. Tripathi, E. Welch, A.R. Tvinnereim, B. Jones, D. Theodorescu, P.F. Barnes, and R. Vankayalapati. Plos Pathogens, 2015. 11(2): p. e1004617. PMID[25659138].

[PubMed]. OI_0130-021215.

21. Synthesis, Antimycobacterial and Antifungal Evaluation of Some New 1-Ethyl-5-(hetero)aryl-6-styryl-1,6-dihydropyrazine-2,3-dicarbonitriles. Verbitskiy, E.V., P.A. Slepukhin, M.A. Kravchenko, S.N. Skornyakov, N.P. Evstigneeva, N.V. Kungurov, N.V. Zil'berberg, G.L. Rusinov, O.N. Chupakhin, and V.N. Charushin. Bioorganic & Medicinal Chemistry Letters, 2015. 25(3): p. 524-528. PMID[25556103].

[PubMed]. OI_0130-021215.

ANTIMALARIAL COMPOUNDS (Plasmodium spp.)

22. The Effect of Lopinavir/Ritonavir on the Antimalarial Activity of Artemether or Artemether/Lumefantrine in a Mouse Model of Plasmodium berghei. Abiodun, O.O., J. Akinbo, and O. Ojurongbe. Journal of Chemotherapy, 2015. 27(1): p. 25-28. PMID[24621166].

[PubMed]. OI_0130-021215.

23. Exploring in Vitro and in Vivo Hsp90 Inhibitors Activity against Human Protozoan Parasites. Giannini, G. and G. Battistuzzi. Bioorganic & Medicinal Chemistry Letters, 2015. 25(3): p. 462-465. PMID[25547934].

[PubMed]. OI_0130-021215.

24. Hydroxamic acid Based Histone Deacetylase Inhibitors with Confirmed Activity against the Malaria Parasite. Giannini, G., G. Battistuzzi, and D. Vignola. Bioorganic & Medicinal Chemistry Letters, 2015. 25(3): p. 459-461. PMID[25563890].

[PubMed]. OI_0130-021215.

25. Salinipostins A-K, Long-chain Bicyclic Phosphotriesters as a Potent and Selective Antimalarial Chemotype. Schulze, C.J., G. Navarro, D. Ebert, J. DeRisi, and R.G. Linington. The Journal of Organic Chemistry, 2015. 80(3): p. 1312-1320. PMID[25584395].

[PubMed]. OI_0130-021215.

26. Uncovering New Structural Insights for Antimalarial Activity from Cost-effective Aculeatin-like Derivatives. Winkler, M., M. Maynadier, S. Wein, M.A. Lespinasse, G. Boumis, A.E. Miele, H. Vial, and Y.S. Wong. Organic & Biomolecular Chemistry, 2015. 13(7): p. 2064-2077. PMID[25519040].

[PubMed]. OI_0130-021215.

Citations from the ISI Web of Knowledge Listings for O.I.

27. Substituted Quinolinones. Part 22. In Vitro Antimicrobial Evaluation of Some 4-Hydroxy-1-methyl-3-pyrazolinylquinolin-2(1H)-ones as Useful Antibiotic Intermediates. Abass, M. and E.S. Othman. Research on Chemical Intermediates, 2015. 41(1): p. 117-125. ISI[000347297200013].

[WOS]. OI_0130-021215.

28. Antimycobacterial Activity of Selected Medicinal Plants Traditionally used in Sudan to Treat Infectious Diseases. Abuzeid, N., S. Kalsum, R.J. Koshy, M. Larsson, M. Glader, H. Andersson, J. Raffetseder, E. Pienaar, D. Eklund, M.S. Alhassan, H.A. AlGadir, W.S. Koko, T. Schon, M.A. Mesaik, O.M. Abdalla, A. Khalid, and M. Lerm. Journal of Ethnopharmacology, 2014. 157: p. 134-139. ISI[000347022700016].

[WOS]. OI_0130-021215.

29. Synthesis of 3-Chloro-4-fluorophenyl-3,4-dichlorophenyl Substituted Thiocarbamide Derivatives as Potential Antitubercular Agents. Arshad, M.F., S. Kumar, A.H. Al Rohaimi, A.A. Hassan, A. Elkerdasy, and N. Upmanyu. Medicinal Chemistry Research, 2015. 24(1): p. 334-343. ISI[000347405700030].

[WOS]. OI_0130-021215.

30. Synthesis and Pharmacological Activities of Some New 2-[1-Heptyl-3-(4-methoxybenzyl)-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]acetohydrazide Derivatives. Beldrcana, O., E. Mentese, and S. Ulkerc. Zeitschrift Fur Naturforschung Section B - A Journal of Chemical Sciences, 2014. 69(9-10): p. 969-981. ISI[000347145200004].

[WOS]. OI_0130-021215.

31. In Vitro Antimicrobial Activity of Pistacia lentiscus L. Edible Oil and Phenolic Extract. Mezni, F., C. Aouadhi, M.L. Khouja, A. Khaldi, and A. Maaroufi. Natural Product Research, 2015. 29(6): p. 565-570. ISI[000347702200014].

[WOS]. OI_0130-021215.

32. DNA Cleavage, Antibacterial, Antifungal and Anthelmintic Studies of Co(II), Ni(II) and Cu(II) Complexes of Coumarin Schiff Bases: Synthesis and Spectral Approach. Patil, S.A., C.T. Prabhakara, B.M. Halasangi, S.S. Toragalmath, and P.S. Badami. Spectrochimica Acta Part A - Molecular and Biomolecular Spectroscopy, 2015. 137: p. 641-651. ISI[000347269900083].

[WOS]. OI_0130-021215.

33. Antimicrobial and Antioxidant Activities of Bauhinia racemosa Lam. and Chemical Content. Rashed, K. and M. Butnariu. Iranian Journal of Pharmaceutical Research, 2014. 13(3): p. 1073-1080. ISI[000347384900035].

[WOS]. OI_0130-021215.

34. Chemical Composition, Antimicrobial and Antioxidant Activities of the Essential Oil of Psammogetoncanescens. Raudone, L., R. Raudonis, K. Gaivelyte, A. Pukalskas, P. Viskelis, P.R. Venskutonis, and V. Janulis. Natural Product Research, 2015. 29(3): p. 281-285. ISI[000346586100013].

[WOS]. OI_0130-021215.

35. Chemical Compositions and Antimicrobial Activity of the Essential Oils of Piper abbreviatum, P. ereeticaule and P. lanatum (Piperaceae). Salleh, W., F. Ahmad, and K.H. Yen. Natural Product Communications, 2014. 9(12): p. 1795-1798. ISI[000346892700035].

[WOS]. OI_0130-021215.

36. New Antimicrobial Pregnane Glycosides from the Stem of Ecdysanthera rosea. Song, C.W., P.K. Lunga, X.J. Qin, G.G. Cheng, J.L. Gu, Y.P. Liu, and X.D. Luo. Fitoterapia, 2014. 99: p. 267-275. ISI[000347019000034].

[WOS]. OI_0130-021215.

37. Design and Applications of Bifunctional Cinnamide Derivatives as Potential Antimycobacterial Agents with Few Hepatotoxic Effects. Wu, Z.R., D.J. Zhi, L.F. Zheng, J.Y. Li, Y. Li, Q.J. Xie, N. Feng, Y.F. Bao, Q.Y. Gao, Y. Song, and H.Y. Li. Medicinal Chemistry Research, 2015. 24(1): p. 161-170. ISI[000347405700014].

[WOS]. OI_0130-021215.

38. Synthesis and Antimycobacterial Evaluation of Natural Oridonin and Its Enmein-type Derivatives. Xu, S.T., L.L. Pei, D.H. Li, H. Yao, H. Cai, H.Q. Yao, X.M. Wu, and J.Y. Xu. Fitoterapia, 2014. 99: p. 300-306. ISI[000347019000038].

[WOS]. OI_0130-021215.

39. Synthesis and Biological Evaluation of Novel D-Glucose-derived 1,2,3-Triazoles as Potential Antibacterial and Antifungal Agents. Zhang, H.Z., J.J. Wei, K.V. Kumar, S. Rasheed, and C.H. Zhou. Medicinal Chemistry Research, 2015. 24(1): p. 182-196. ISI[000347405700016].

[WOS]. OI_0130-021215.